Works by Crump, Michael

Results: 104
    1
    2
    3
    4
    5

    The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing.

    Published in:
    Molecular Informatics, 2013, v. 32, n. 1, p. 47, doi. 10.1002/minf.201200114
    By:
    • Kohonen, Pekka;
    • Benfenati, Emilio;
    • Bower, David;
    • Ceder, Rebecca;
    • Crump, Michael;
    • Cross, Kevin;
    • Grafström, Roland C.;
    • Healy, Lyn;
    • Helma, Christoph;
    • Jeliazkova, Nina;
    • Jeliazkov, Vedrin;
    • Maggioni, Silvia;
    • Miller, Scott;
    • Myatt, Glenn;
    • Rautenberg, Michael;
    • Stacey, Glyn;
    • Willighagen, Egon;
    • Wiseman, Jeff;
    • Hardy, Barry
    Publication type:
    Article
    6
    7
    8
    9
    10

    Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 12, p. 1538, doi. 10.1002/ajh.26726
    By:
    • Lackraj, Tracy;
    • Ben Barouch, Sharon;
    • Medeiros, Jessie J. F.;
    • Pedersen, Stephanie;
    • Danesh, Arnavaz;
    • Bakhtiari, Mehran;
    • Hong, Michael;
    • Tong, Kit;
    • Joynt, Jesse;
    • Arruda, Andrea;
    • Minden, Mark D.;
    • Kuruvilla, John;
    • Bhella, Sita;
    • Kukreti, Vishal;
    • Crump, Michael;
    • Prica, Anca;
    • Chen, Christine;
    • Deng, Yangqing;
    • Xu, Wei;
    • Pugh, Trevor J.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 2, p. 252, doi. 10.3109/10428190903585286
    By:
    • Crump, Michael;
    • Hedley, David;
    • Kamel-Reid, Suzanne;
    • Leber, Brian;
    • Wells, Richard;
    • Brandwein, Joseph;
    • Buckstein, Rena;
    • Kassis, Janine;
    • Minden, Mark;
    • Matthews, John;
    • Robinson, Sue;
    • Turner, Robert;
    • Mcintosh, Lynn;
    • Eisenhauer, Elizabeth;
    • Seymour, Lesley
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial.

    Published in:
    Current Oncology, 2021, v. 28, n. 2, p. 1256, doi. 10.3390/curroncol28020119
    By:
    • Prica, Anca;
    • Hay, Annette E.;
    • Crump, Michael;
    • Mittmann, Nicole;
    • Shepherd, Lois E.;
    • Meyer, Ralph M.;
    • Imrie, Kevin I.;
    • Risebrough, Nancy;
    • Djurfeldt, Marina;
    • Chen, Bingshu E.;
    • Cheung, Matthew C.
    Publication type:
    Article
    27
    28

    P025: RADAR: An international phase III, PET response‐adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited‐stage classical Hodgkin lymphoma.

    Published in:
    HemaSphere, 2022, v. 6, p. 12, doi. 10.1097/01.HS9.0000890668.27643.97
    By:
    • Radford, John;
    • Adedayo, Toyin;
    • Ardavan, Arzhang;
    • Barrington, Sally F.;
    • Berkahn, Leanne;
    • Chauvie, Stephane;
    • Clifton‐Hadley, Laura;
    • Collins, Graham P.;
    • Crump, Michael;
    • Cutter, David;
    • Edwards, Darren;
    • Hutchings, Martin;
    • Illidge, Tim;
    • Kirkwood, Amy A.;
    • Linton, Kim;
    • Moskowitz, Craig H.;
    • Patrick, Pip;
    • Phillips, Beth;
    • Shepherd, Lois;
    • Tonino, Sanne
    Publication type:
    Article
    29
    30
    31
    32

    Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience

    Published in:
    2020
    By:
    • Sawas, Ahmed;
    • Ma, Helen;
    • Kuruvilla, John;
    • Lue, Jennifer K.;
    • Deng, Changchun;
    • Marchi, Enrica;
    • Montanari, Francesca;
    • Cheng, Bin;
    • Savage, Kerry J.;
    • Villa, Diego;
    • Crump, Michael;
    • Connors, Joseph M.;
    • O'Connor, Owen A.
    Publication type:
    Letter
    33
    34
    35

    A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 912, doi. 10.1080/10428194.2018.1515937
    By:
    • Reiman, Tony;
    • Savage, Kerry J.;
    • Crump, Michael;
    • Cheung, Matthew C.;
    • MacDonald, David;
    • Buckstein, Rena;
    • Couban, Stephen;
    • Piliotis, Eugenia;
    • Imrie, Kevin;
    • Spaner, David;
    • Shivakumar, Sudeep;
    • Kuruvilla, John;
    • Villa, Diego;
    • Shepherd, Lois E.;
    • Skamene, Tanya;
    • Winch, Chad;
    • Chen, Bingshu E.;
    • Hay, Annette E.
    Publication type:
    Article
    36
    37
    38
    39

    Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 10, p. 2319, doi. 10.1080/10428194.2017.1312379
    By:
    • Skamene, Tanya;
    • Crump, Michael;
    • Savage, Kerry J.;
    • Reiman, Tony;
    • Kuruvilla, John;
    • Good, David;
    • LeBrun, David;
    • Meyer, Ralph M.;
    • Sehn, Laurie H.;
    • Soulières, Denis;
    • Stakiw, Julie;
    • Laferriere, Nicole;
    • Luminari, Stefano;
    • Shepherd, Lois E.;
    • Djurfeldt, Marina;
    • Zhu, Liting;
    • Chen, Bingshu E.;
    • Hay, Annette E.
    Publication type:
    Article
    40

    The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 6, p. 1358, doi. 10.1080/10428194.2016.1239259
    By:
    • Seftel, Matthew D.;
    • Kuruvilla, John;
    • Kouroukis, Tom;
    • Banerji, Versha;
    • Fraser, Graeme;
    • Crump, Michael;
    • Kumar, Rajat;
    • Chalchal, Haji I.;
    • Salim, Muhammad;
    • Laister, Rob C.;
    • Crocker, Susan;
    • Gibson, Spencer B.;
    • Toguchi, Marcia;
    • Lyons, John F.;
    • Xu, Hao;
    • Powers, Jean;
    • Sederias, Joana;
    • Seymour, Lesley;
    • Hay, Annette E.
    Publication type:
    Article
    41
    42

    Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 1, p. 64, doi. 10.1080/10428194.2016.1187274
    By:
    • Baetz, Tara;
    • Chen, Bingshu E.;
    • Couban, Stephen;
    • Tom Kouroukis, C.;
    • Buckstein, Rena;
    • Kuruvilla, John;
    • Howson-Jan, Kang;
    • Szwajcer, David;
    • Federico, Massimo;
    • Meyer, Ralph M.;
    • Djurfeldt, Marina S.;
    • Hay, Annette E.;
    • Shepherd, Lois;
    • Crump, Michael
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer's pathophysiology and susceptibility.

    Published in:
    Molecular Neurodegeneration, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13024-015-0015-x
    By:
    • Sevlever, Daniel;
    • Fanggeng Zou;
    • Li Ma;
    • Carrasquillo, Sebastian;
    • Crump, Michael G.;
    • Culley, Oliver J.;
    • Hunter, Talisha A.;
    • Bisceglio, Gina D.;
    • Younkin, Linda;
    • Allen, Mariet;
    • Carrasquillo, Minerva M.;
    • Sando, Sigrid B.;
    • Aasly, Jan O.;
    • Dickson, Dennis W.;
    • Graff-Radford, Neill R.;
    • Petersen, Ronald C.;
    • Morgan, Kevin;
    • Belbin, Olivia
    Publication type:
    Article
    50